Future outperforming subsectors in pharma

Future outperforming subsectors in pharma

Oncology, immunology & neurology will outperform the overall pharmaceutical sector over the coming decade. Innovation will drive this out-performance. IQVIA estimates annual spending on oncology and immunology will reach US$ 273bn and US$ 175bn respectively, with over 100 new...

Continue reading →

Drug approval in the healthcare markets EU vs. US

Drug approval in the healthcare markets EU vs. US

Continue reading →

Drugs affordability vs R&D development

Drugs affordability vs R&D development

Continue reading →

Hospital margins are down – is selling your health data a solution

Hospital margins are down – is selling your health data a solution

A framework allowing a more sensible approach to health data collection In our previous blog we outlined the pressure on hospital margins and the entire hospital business model as a direct result of Covid-19. One solution is the sale by...

Continue reading →

Why are drug prices rising faster than inflation?

Why are drug prices rising faster than inflation?

Drug makers typically raise prices at the beginning of the year and this year is no different. Prices on 457 brand name drugs are due to increase this year by an average of 5.1%. (GoodRx). About 102 drug manufacturers,...

Continue reading →

Healthcare Industry Outlook 2020 Market Overview

Healthcare Industry Outlook 2020 Market Overview

The healthcare industry is one of the largest and fastest growing industries globally. By 2040, the World Economic Forum (WEF) predicts that USD 25 trillion will be spent on healthcare up from US$ 11.9 trillion in 2018. Market consensus...

Continue reading →